Clinical trial
In-hospital Initiation of PCSK9 Inhibitor and Short-term Lipid Profile Alteration, as Well as In-hospital Mortality and Readmission Rate in Patients With Acute Myocardial Infarction
NCT05184530 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- In-hospital Initiation of PCSK9 Inhibitor and Short-term Lipid Profile Alteration, as Well as In-hospital Mortality and Readmission Rate in Patients With Acute Myocardial Infarction
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- December 31, 2021
- Enrollment
- 7,556 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.